Vascular Endothelial Growth Factor A (VEGFA) Antibody

Pida mas información
935106861
info@markelab.com
Precio
292.5€ (80 µl)
Antibody anti-VEGFA
proveedor
Abbexareference
abx026640Tested Applications
ELISA, WBreactivity
Humanstatus
RUOclonality
PolyclonalDescripción
This gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. There is also evidence for the use of non-AUG (CUG) translation initiation sites upstream of, and in-frame with the first AUG, leading to additional isoforms.
Background
VEGFA is a key member of the vascular endothelial growth factor (VEGF) family and plays a crucial role in angiogenesis, vascular permeability, and endothelial cell proliferation VEGFA binds primarily to its receptors VEGFR-1 and VEGFR-2, triggering signaling pathways like PI3K/AKT and ERK/MAPK to promote blood vessel formation during embryonic development, wound healing, and tissue repair Dysregulated VEGFA expression is associated with pathological angiogenesis observed in cancer, diabetic retinopathy, and age-related macular degeneration (AMD) VEGFA also increases vascular permeability by altering endothelial junctions, contributing to fluid leakage in conditions such as inflammation and tumors Targeted therapies, such as bevacizumab and other anti-VEGF agents, inhibit VEGFA activity to suppress angiogenesis and tumor growth in various cancers and ocular diseases
Características del producto
category
Primary Antibodies
clonality
Polyclonal
reactivity
Human
immunogen target
Vascular Endothelial Growth Factor A (VEGFA)
host
Rabbit
isotype
IgG
conjugation
Unconjugated
form
Liquid
tested applications
ELISA, WB
purification
Purified through a protein A column, followed by peptide affinity purification.
recommended dilution
WB: 1/1000. Optimal dilutions/concentrations should be determined by the end user.
buffer
PBS containing 0.09% sodium azide.
size 1
80 µl
size 2
400 µl
storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
or code
VEGFA
dry ice
No
availability
Shipped within 5-10 working days.
alias
L-VEGF,MVCD1,VEGF,VPF,Vascular permeability factor
uniprot id
Quizá le pueda interesar
Canine VEGF(Vascular Endothelial cell Growth Factor) ELISA Kit

proveedor
FineTestreference
ECA0022reactivity
caninestatus
RUOPrecio a consultar
Ver másGuinea pig VEGF-A(Vascular Endothelial cell Growth Factor A) ELISA Kit

proveedor
FineTestreference
EGP0053reactivity
guinea pigstatus
RUOPrecio a consultar
Ver másHuman VEGF(Vascular Endothelial Cell Growth Factor) ELISA Kit

proveedor
FineTestreference
EH0327reactivity
humanstatus
RUOPrecio a consultar
Ver más